You have 9 free searches left this month | for more free features.

Talazoparib

Showing 1 - 25 of 87

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Washington, Charlotte, Salt Lake City (Talazoparib, Avelumab)

Recruiting
  • Breast Cancer
  • Washington, District of Columbia
  • +2 more
Mar 14, 2022

Advanced or Recurrent Solid Tumors, Breast Tumor Trial in Tirana, Z├╝rich (Injections Subcutaneously Talazoparib, Oral capsules

Not yet recruiting
  • Advanced or Recurrent Solid Tumors
  • Breast Neoplasm
  • Injections Subcutaneously Talazoparib
  • Oral capsules Talazoparib
  • Tirana, Albania
  • +1 more
Oct 17, 2021

Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial (Pidnarulex, Talazoparib)

Not yet recruiting
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jun 15, 2022

Lung Cancer, Small-Cell Lung Cancer Trial in Toronto (Talazoparib in Combination with Low Dose Radiotherapy (RT))

Recruiting
  • Lung Cancer
  • Small-Cell Lung Cancer
  • Talazoparib in Combination with Low Dose Radiotherapy (RT)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Center, University Health Network
Feb 25, 2022

Acute Myeloid Leukemia Trial in Stanford (Talazoparib, Topotecan, Gemcitabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Talazoparib
  • +2 more
  • Stanford, California
    Stanford University
Jun 10, 2022

Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Talazoparib, Tazemetostat)

Recruiting
  • Metastatic Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Jul 18, 2022

Advanced Breast Cancer Trial in Seoul (Talazoparib Oral Capsule)

Recruiting
  • Advanced Breast Cancer
  • Talazoparib Oral Capsule
  • Seoul, Korea, Republic of
    Seoul National University Hospital
May 14, 2021

Premenopausal HR+/HER2- Metastatic Breast Cancer Trial in Seoul (Pabociclib, Endocrine, Talazoparib, Atezolizumab, Pabociclib,

Not yet recruiting
  • Premenopausal HR+/HER2- Metastatic Breast Cancer
  • Pabociclib, Endocrine, Talazoparib, Atezolizumab
  • Pabociclib, Endocrine, Talazoparib,
  • Seoul, Korea, Republic of
    Samsung mendical Center
Jul 26, 2021

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Pittsburgh (ZEN003694, Talazoparib)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Apr 27, 2022

US Talazoparib-Treated Locally Advanced or Metastatic Breast

Completed
  • Breast Cancer
  • Talazoparib
  • New York, New York
    Pfizer Inc
Nov 22, 2021

Tumors Trial in Changchun, Beijing (talazoparib)

Completed
  • Neoplasms
  • talazoparib
  • Changchun, Jilin, China
  • +1 more
Jan 12, 2022

Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
May 31, 2022

Metastatic or Unresectable Melanoma Trial in Cleveland (Nivolumab, Talazoparib)

Recruiting
  • Metastatic or Unresectable Melanoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Mar 22, 2022

Breast Cancer Trial in Boston (Talazoparib, Sacituzumab Govitecan)

Recruiting
  • Breast Cancer
  • Talazoparib
  • Sacituzumab Govitecan
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Oct 25, 2021

Metastatic Breast Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Ovarian Carcinoma Trial in Ann Arbor

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Mar 31, 2022

BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

Recruiting
  • BRCA1 Mutation
  • +4 more
  • Talazoparib Oral Capsule
  • Providence, Rhode Island
  • +1 more
Jul 19, 2022

Recurrent Glioma, Recurrent Glioblastoma, Poly ADP Ribose Polymerase (PARP) Inhibitor Trial in Hong Kong (Talazoparib)

Recruiting
  • Recurrent Glioma
  • +4 more
  • Talazoparib
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
Aug 19, 2021

HRD 100 Gene Expression High, Triple Negative Breast Cancer Trial in Kuala Lumpur (Talazoparib)

Recruiting
  • HRD 100 Gene Expression High
  • Triple Negative Breast Cancer
  • Talazoparib
  • Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
    University Malaya Medical Centre
Mar 15, 2022

Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +5 more
  • BET Bromodomain Inhibitor ZEN-3694
  • Talazoparib
  • (no location specified)
Aug 3, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Axitinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 21, 2022

Advanced Refractory Solid Tumors, Advanced Triple Negative Breast Cancers, Metastatic Triple Negative Breast Cancers Trial in

Recruiting
  • Advanced Refractory Solid Tumors
  • +2 more
  • Singapore, Singapore
    National University Hospital
Aug 31, 2021

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Brunswick,

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • New Brunswick, New Jersey
  • +2 more
Jun 28, 2022

Prostate Cancer Metastatic Trial in Boston (Telaglenastat, Talazoparib)

Not yet recruiting
  • Prostate Cancer Metastatic
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 27, 2021

Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer

Recruiting
  • Adrenal Gland Pheochromocytoma
  • +3 more
  • Computed Tomography
  • +2 more
  • Bethesda, Maryland
  • +1 more
Aug 16, 2022